跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Valsadex-165 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Valsadex-165
Approved
STANDARD
Valsadex-165
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
42c18dabb9e7b942
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
42c18dabb9e7b942
Drug Approval Philippines Name
Valsadex-165
Product Name
Valsadex-165
Registration Number
DRP-8914-02
Brand Name
Valsadex-165
Generic Name
Valsartan + Amlodipine (as besilate)
Dosage Form
Film-Coated Tablet
Dosage Strength
160 mg/5 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Labmate Pharma Inc.
Issuance Date
25 July 2024
Expiry Date
24 June 2030
Pharmacologic Category
Angiotensin II Receptor Blocker (ARB) / Calcium Channel Blocker (CCB)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
42c18dabb9e7b942
Type
Standard
Back to Philippines FDA Approvals